Page 204 - Read Online
P. 204

Salas et al. J Cancer Metastasis Treat 2018;4:15  I  http://dx.doi.org/10.20517/2394-4722.2017.66                              Page 9 of 13


                                                   Table 5. Survival analysis
                                                   5-year-OS       P         5-year-DFS     P
                         All group                  43.9%                      44.5%
                         Age
                           ≤ 60 years               56.1%                      41.8%
                           > 60 years               38.9%         0.667        45.8%       0.643
                         Gender
                           Female                   53.4%                      51.0%
                           Male                     31.2%         0.539        37.8%       0.323
                         Tobacco
                           Yes                      21.9%                      52.5
                           No                       46.2%         0.597        43.7        0.815
                         Alcohol
                           Yes                      0.0%*                      40.0%**
                           No                       46.6%         0.634        44.8%       0.507
                         Location
                           Hard palate              66.7%                      53.3%
                           Upper alveolus           42.7%         0.707        43.6%       0.851
                         cT
                           T2-T3                    69.3%                      44.2%
                           T4                       36.7%         0.019        44.0%       0.743
                         Grade
                           Poor/moderate differentiation  47.0%                51.7%
                           Well differentiated      42.1%         0.715        39.9%       0.289
                         PNI
                           No                       61.2%                      52.4%
                           Yes                      26.1%         0.039        36.3%       0.334
                         LVI
                           No                       48.8%                      50.9%
                           Yes                      23.5%         0.021        24.7%       0.026
                         P16
                           Negative                 27.9%                      35.0%
                           Positive                 100.0%        -            100.0%      -
                         Neck dissection
                           No                       53.4%                      50.1%
                           Yes                      18.8%         0.010        29.6%       0.129
                         pN
                           N-                       48.5%                      48.7%
                           N+                       25.1%         0.340        31.0%       0.278
                         Neck recurrence
                           No                       52.3%
                           Yes                      9.3%          0.064
                         N+ and N- with neck recurrence
                           No                       55.5%
                           Yes                      21.6%         0.192

                         *Estimated at 41 months; **estimated at 9 months. PNI: perineural invasion; LVI: lymphovascular infiltration

                                                                      [30]
               and clinical stage was the most important prognostic indicator . Recent retrospective series with 26 to
               146 upper alveolar ridge and hard palate cases reported a neck lymph node involvement between 11% and
               36.6%, and regional recurrence in N0 neck from 14% to 27% [1,5-8] . These studies had several findings: cases
               with neck node involvement had higher grade; clinical stage but not margin status was associated with
               prognosis; and T3 (55%) and T4 (52%) tumors exhibited higher rates of neck lymph node involvement than
               smaller tumors (T1 = 15%; T2 = 28%). An analysis of the Surveillance, Epidemiology, and End Results (SEER)
               database evaluated 314 hard palate SCC and 411 upper alveolar ridge cases. They found a 13.65% prevalence
               of cervical metastasis and its correlation with larger tumor (4.1% for T1 to 24.7% for T4 tumors, P < 0.001).
               Extension of lymph node involvement was correlated to survival (P < 0.001).
   199   200   201   202   203   204   205   206   207   208   209